Top compounds associated with response to MYBL2


Feature Type Standardized
Nominal ANOVA
mRNA NVP-BEZ235 CTRPv2 pan-cancer AAC 0.12 0.01
mRNA MI-2 CTRPv2 pan-cancer AAC 0.15 0.01
mRNA XL-184 GDSC1000 pan-cancer AAC -0.091 0.01
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.096 0.01
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.01
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.01
mRNA PLX4720 CTRPv2 pan-cancer AAC -0.093 0.01
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.01
mRNA Topotecan CTRPv2 pan-cancer AAC 0.084 0.01
Download CSV